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 INTRODUCTION 
Epilepsy and Migraine are the chronic disorders with recurrent neurological 
dysfunction associated with headache and autonomic,abdominal and psychotic 
features. In some patients it may be difficult to differentiate between migraine and 
the seizure episodes. Both are having comorbid  symptoms and 
occurrence.Migraine patients can develop seizure and epileptics can have migraine 
attacks. Epileptologists proposed the hyperexcitabilty of the altered brain tissue, as 
the cause of  seizure and migraine headache occurrence and vice 
versa.Enhancedhyperexcitability of cortical neurons and diminished threshold are 
the pathophysiological mechanisms enumerated in these conditions. Low 
magnesium in brain and the altered neurotransmitters are responsible for increased 
cortical excitability.Both the environmental as well as the genetic factors might 
cause these changes. 
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AIMS  AND  OBJECTIVES  OF STUDY 
1.To study the incidence of various  headaches which can occur periictally and 
interictally in patients with known primary generalised epilepsy. 
2.To evaluate the association  of headache, with the seizure and its impact on the 
patient‟s lifestyle. 
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REVIEW OF LITERATURE 
Epilepsy and Migraine are the chronic disorders with recurrent neurological 
dysfunction associated with headache and autonomic,abdominal and psychotic 
features
1
.In some patients it may be difficult to differentiate between migraine and 
the common epileptic attacks.In the developed countries epilepsy incidence in 
young persons are 100-200/1lakh/yr and >200/1lakh/yr in older population
2
.The 
prevalence studies showed, total rate of 5-6/1000.The prevalence rate is somewhat 
constant in developed nations of variable geographical distributions.But  highest, 
migraine prevalence is seen in American and European countries  and  lowest in 
asiancountries. Both epilepsy and  migraine are inversely related with economic 
condition of people. A lifetime prevalence study revealed that as many as 93 per 
cent of men, experienced a headache at some time and  the most common cause 
being the tension-type headache (69 per cent)
3
. For women, the lifetime prevalence 
was 99 percent.Here also  tension-type headache is the most common (88 per 
cent)type. Although such a high prevalence suggests a commonplace, almost trivial 
symptom, it can nevertheless be a symptom of grave significance. It is thus a major 
cause for attendance in neurological outpatient clinics, representing approximately 
15 per cent of routine neurological attendance  and makes more anxious in both 
patients as well as doctor side.  Thus every patient with headache must be given 
importance and needs complete investigations sometimes. Although most patients 
   
 
with headache will not contact their doctor and those with frequent headache, and 
with migraine constitute a significant public health and economic problem.  
In 1985, the International Headache Society (IHS) established a classification 
committee which published the first international headache classification in 1988, 
including the operational diagnostic criteria
4
.This has been adopted by the World 
Federation of Neurology and the World Health Organization, which has 
incorporated the main features in the international classification of diseases (ICD-
10). The classification provides 13 broad categories which are then subdivided, to 
allow for coding up to a four-digit level. The extent of the subclassification thus 
depends upon the degree of sophistication required. The classification has been an 
important advance, primarily for research but increasingly for clinical 
management. It is gradually replacing the previous variable terminology which 
included the  classic migraine, common migraine,  psychogenic headache, and 
essential headache. 
 
 
 
 
 
   
 
 
 
Table 3.1. Classification of headache (data from Headache Classification 
Committee of the International Headache Society 1988)
13 
 
Migraine 
Tension-type headache 
Cluster headache and chronic paroxysmal hemicrania 
Headache associated with head trauma 
Headache associated with vascular disorders 
Headache associated with non-vascular intracranial disorders 
Headache associated with substances and their withdrawal 
Headache associated with non-cephalic infection 
Headache associated with metabolic abnormality 
Headache or facial pain associated with disorders of cranium, neck, eyes, ears, 
nose sinuses, teeth, mouth, or other facial or cranial structures 
Cranial neuralgias, nerve trunk pain, and differentiation pain 
Other types of headache or facial pain 
Headache not classifiable 
 
 
   
 
Revisions of the IHS classification have been proposed. For example, refocusing 
on the old problem of patients with very frequent headache, often referred to as 
chronic daily headache or addition of new entities, such as the short-lasting 
unilateral neuralgiform headache attacks with conjunctival injection and tearing 
(SUNCT) syndrome have been proposed. 
ANATOMY AND PHYSIOLOGY OF HEADACHE: 
All the tissues which covers the cranium are pain sensitive mainly the arteries and   
the muscles, pericranium. The skull bone  is insensitive to pain. Within the 
cranium, the venous sinuses and their tributaries, the dura mater and the cerebral 
arteries, and the fifth, ninth, and tenth cranial nerves are the chief pain-sensitive 
structures. The main factors causing headache have been considered to be: 
 inflammation involving pain-sensitive structures of the head; 
 referred pain; 
 meningeal irritation; 
 traction on or dilatation of blood vessels; 
 pressure upon or distortion of pain-sensitive structures caused by tumours or 
other lesions; and 
 psychological causes, when the pain is considered in some instances to be 
due to tension in the muscles of the scalp and neck. 
   
 
However, such a classical view of headache production does not readily explain 
the mechanisms of headache in migraine and tension-type headache. A more 
precise understanding is now emerging which implicates, all levels of the 
innervation of cranial structures .The somatosensory innervation to the head is 
primarily from the trigeminal nerve and upper cervical spinal-cord segments
5
. The 
original studies by Penfield and colleagues on awake patients during the surgery 
identified that traction of the pain-sensitive meninges
6
 and meningeal vessels
7
 
could give rise to severe headache, but by contrast, the brain parenchyma was not 
pain sensitive. The trigeminal innervation of the meninges and meningovascular 
structures are via the small, unmyelinated C fibres.Activation of the caudal 
trigeminal nucleus and the dorsal horn at the C1/2 level can be demonstrated by c-
fos immunocytochemistry, a method for showing activation of cells following 
stimulation of both vessels and meninges in animals.Activation of 
trigeminovascular fibres is also accompanied by release of the neuropeptides, 
substance P, and calcitonin-gene-related peptide (CGRP)
8
. The second-order 
pathway from the caudal trigeminal nucleus is via the quintothalamic tract 
primarily to the ventroposteromedial nucleus of the thalamus . 
 
 
   
 
Sensitization of the trigeminal pathway may be important in the generation of 
some headaches, for example that associated with migraine which can be 
exacerbated by coughing and sudden head movement. Exacerbation by movement 
is a classic feature of the headache associated with intracranial pathology, when it 
is thought to be due to the mechanical stimulation of meningeal vessels. In 
animals, recording of primary afferent neurons in the trigeminal ganglion has 
shown that chemical stimulation of the dural receptive field with inflammatory 
mediators
9
 directly excites the neurons, but in addition, enhances their mechanical 
sensitivity. Thus neurons may be strongly activated by mechanical stimuli that 
normally excite little or no response .In addition to mapping the early components 
of pain processing, cognitive factors are increasingly recognized as being 
important in the central modulation of headache pain.  
DIFFERENTIAL DIAGNOSIS AND CLINICAL APPROACH: 
While asking headache details, following points must be paid more attention. How 
long does thepatient have headache? Is it increasing in severity? Is it constant or 
paroxysmal innature and if paroxysmal, what is the duration of the attack and do 
they occur at any special time of a day? Are the headaches precipitated by any 
circumstance or activity, and how can they be relieved? What is the character of 
headache and the situation? Is there associated tenderness over the scalp or skull, 
or visual disturbances, vomiting  or vertigo? Had  there been a head injury? Are 
   
 
there symptoms of nasal obstruction or discharge, either from the nose or into the 
pharynx? Is the patient anxious, tense, or depressed? Physical examination should 
include a general assessment which must include the blood pressure. 
Investigations will be dictated by the history and the findings; ranging from the 
ESR and temporal artery biopsy in patients whose history is indicative of cranial 
arteritis, through to neuroimaging. The decision of when to undertake 
neuroimaging can be difficult. Many features may influence the decision, including 
the anxiety of the patient and referring physician. However, patients with long-
standing symptoms of tension-type headache are rarely found to have an 
underlying structural lesion. Similarly, patients with a typical history of migraine 
need not undergo neuroimaging. Thus, in a previous study of 547 patients with a 
typical history and normal examinations, only four had an abnormality on CT scan. 
TENSION HEADACHE AND DEPRESSION:
3 
Headache is one of the most  common phenomenon, experienced by most persons 
in their life , particularly during  stress and fatigue.  
One of the most commonpresentations of headache is a sense of pressure over the 
vertex or the sense of a tight band that is present most of the day, but is usually 
worse in the evening. It is quite often felt in association with anxiety and in some 
patients with depression, although it may be difficult to know which was the 
causeandtheeffect. The IHS classification uses the term „tension-type headache‟, to 
   
 
imply in some patients, an abnormality of pericranial muscle. It is classified either 
as episodic or chronic type. It is likely that the underlying pathophysiology is 
heterogenous. Although there may be sensitive trigger points in pericranial 
muscles, it has been difficult to demonstrate abnormalities consistently with 
electromyogram (EMG) studies. Patients with other headaches, such as migraine, 
often suffer from coexistent tension-type headache. The headache does not usually 
interfere with daily activity and is less often exacerbated by physical activity than 
migraine. Similarly, photophobia, phonophobia, and nausea are much less 
prominent than with migraine and typically the headache is bilateral rather than 
unilateral in nature. 
Tension headache can be difficult to treat. Simple analgesics may provide relief, 
and ibuprofen is generally the first choice before aspirin. The use of a tricyclic 
antidepressant as a prophylactic, starting at a low dose (for example 10–25 mg of 
amitriptyline), can be beneficial .A danger in the treatment of tension-type 
headache, however, is a vicious cycle of increasing medication, with the 
emergence of drug-induced headache which can change the pattern of episodic 
tension type headache into a chronic one. Drug-induced headache is most 
commonly recognized in the  headache clinics, where patients present with a long 
history of  migraine or, less commonly, tension-type headache .The withdrawal of 
analgesics in regular users can result in a rebound headache, thus leading to 
   
 
sustained high levels of analgesic consumption. Withdrawal of caffeine, which is 
used in a number of migraine medications, can also result in rebound headache .A 
careful analgesic drug history is important. Although withdrawal of analgesics 
and/or caffeine may initially exacerbate symptoms, it can often change chronic 
tension headache into a more manageable episodic pattern.Patients with  
depressive illness  often have coexistent headache, which can be delusional in 
nature. Sometimes these patients will have  night-time headache or early morning 
headache due to the disturbed sleep pattern  with early morning awakening.  
MIGRAINE: 
 Migraine headache is known to medical science for nearly 2000 years
11
. In 
the first century of the Christian era, Aretaeus of Cappadocia referred to it as 
heterocrania, and the term hemicrania ( migraine  derived from this word) was 
introduced by Galen (AD 131–201). A key feature of migraine headache is that it 
is periodic in nature , with attacks lasting usually between 4 and 72 hours
12
. 
Typical features, although not exclusive, are that it is usually unilateral and 
pulsatile in nature. Operational diagnostic criteria (International Headache 
Classification) require that the headache is associated with  nausea or vomiting 
and/or photophobia or phonophobia. The headache itself may or may not be 
associated with an aura of preceding neurological symptoms. During the latter, 
characteristic changes in brain  blood flow may be demonstrated. 
   
 
FREQUENT MIGRAINE: 
Recurrent attacks of headache lasting for 4-72 hrs with the following features and 
with normal physical examination and  no secondary causes for headache. 
Atleast two of
32 
1.Unilateral headache 
2.Throbbing type 
3.Movement aggravation 
4.Moderate to severe in nature 
Atleast  1of the following 
1.Nausea or vomiting 
2.Photophobia ,phonophobia 
The International Headache Classification (Headache Classification Committee of 
the International Headache Society 1988)
13
 distinguishes between migraine with 
aura and migraine without aura .The former subsumes a number of migraine 
subtypes or variants. This classification replaces the earlier terms of classic  
migraine, referring to those with aura, and common or simple migraine, referring 
to those without aura. The new classification is quite explicit and avoids confusion. 
   
 
Migraine with and without aura can, of course, both occur in an individual patient. 
Migraine with aura is most common in women around 12-13yrs(14.1/1000 person 
/yr) but without aura peaks in between 14-17yrs(18.9/1000 person yrs)
14
of 
age.Migraine with aura occurs early in boys(6.6/1000/yr at five yrs) and 
consequently more prevalent in boys than in girls.Menstrual hormones are 
responsible for the increased risk of migrainous headache at menarche and also 
during the reproductive life period of the women. 
Both Migraine and seizure disorder have comorbid symptoms and 
occurrence.Migraine patients can develop seizure and epileptic patients can have 
migraine attacks.Migraine prevalence is 24% between the epileptic probands and 
26% in their relatives.1-17% is the epilepsy prevalence in migraineurs
15
. To 
explain the comorbidity there are 3 models available now. Unidirectional causal 
link is the first possibility. If migraine produces seizure by causing cerebral 
ischemia, then the migraine incidence will be more before seizure 
occurs.Conversly by the induction of trigeminovascular
15
 system, epilepsy can 
cause migraine, in whichcase migraine incidence will be more after epileptic 
attack.So the unidirectional link was rejected, because of the increased risk of 
migraine prior to and after the seizure. Environmental factors will share the next 
possibility .Since migraine is more common in elderly individuals having 
   
 
cryptogenic seizure, the unidirectional link   was also deleted.Third possibility, 
deals with the genetic susceptibility between these 2 conditions. 
Finally epileptologists proposed the hyperexcitabilty of the altered brain 
tissue,whichcan raise the risk of seizure and migraine headache ,and vice versa, as 
the most suitable explanation.Enhancedhyperexcitability
16
 of cortical neurons and 
diminished threshold are the pathophysiological mechanisms enumerated in these 
conditions. Low magnesium in brain and the altered neurotransmitters are 
responsible for increased cortical excitability.Both the  environmental as well as 
genetic factors might cause these changes. 
TEMPORAL RELATIONSHIP AMONG EPILEPSY AND MIGRAINE 
SYMPTOMS:
17 
In epileptic patients headache can occur during  
a)Ictal  
b)Pre&Postictal and  
c) Interictal state. 
Migraine without aura  as well as  tension type  headache are more common in 
preictal and in periictal periods. Spreading depression,neurotransmitter alterations 
are the causes of higher incidence of migraine headaches during epileptic attack
18
. 
   
 
Patients usually will not tell the preictal and ictal headaches because of the seizure 
but if we carefully ask they will tell the headache.Ictal headache can be an isolated 
manifestation of a seizure or a predominant symptom of a seizure.It usually occurs 
in the frontal region as a throbbing type of headache lasting for <1mt of mild to 
moderate severity.Hemicranial pain can occur with parietal lobe epilepsy. Postictal 
headache is the most common type of headache in Occipital lobe epilepsy and in 
Mesial temporal sclerosis,the post ictal headache occurs very frequently .Unilateral  
and frontotemporal region is the commonest site of headache .Tension headache 
can occur in postictal period.Headache can be provoked by seizure. Likewise  
seizure can be initited by migraine aura which is called as Migralepsy.  IHS-ii 
criteria(2004) for  migralepsy require
19
: 
1.Migraine headache fulfilling the  criteria to say migraine with aura. 
2.Seizure that occurs within 1hour of migraine with aura. 
Migraine triggered seizures  commonly associated with basilar migraine and 
catamenialepilepsy.In sometimes, Basilar migraine can be difficult to differentiate  
from complex partial seizures.Catamenial epilepsy and migraine with aura, are 
interchangeable risk factors for migralepsy. 
 
 
   
 
EPILEPTIC SYNDROMES,MIGRAINE AND MIGRAINE LIKE SEIZURES: 
In  idiopathic childhood occipital lobe epilepsy and Rolandic epilepsy migraine 
and migraine like seizure can occur.In most patients with occipital lobe epilepsy, 
family history will be present  and 25-40% of them will have headaches following 
seizure.Headache most commonly occur during the onset of seizure can be 
misdiagnosed as migraine.Rolandicepileptics can develop headache, during seizure 
evolution and many of them develop migraine after the seizure. 
EPILEPSY AND FAMILIAL HEMIPLEGIC MIGRAINE GENETICS: 
FHM is an autosomal dominant disorder and it is a  variant of migraine with 
aura.In type 2FHM there  may be a loss of sodium potassium ATPase function 
which may depolarize the cortical neurons producing hyperexcitability and then 
fits.In, FHM3 mutation in the SCN1A gene  can cause GEFS plus and myoclonic 
epilepsy.Fits can occur during the hemiplegic migraine attack.It may be partial or 
generalised or secondarily generalised and it  may occur initially or during the 
episode of headache.Ion channel dysfunction is the key for both neuronal 
hyperexcitability and cortical spreading depression
20
. 
Migraine can produce cortical infarcts which can initiate seizures.Thus patients 
with epilepsy having migraine also, will have a poor prognosis. Migraine may be 
associated with increased risk of ischemic stroke in women but not in 
   
 
men.Channelopathies
21
 are the basis for genetic linkage between these two 
interrelated disorders.Focalcerebaledema in the suparatentorial region can occur 
with migraine triggered fits.EEG is usually normal, though diffuse slowing can 
occur.IHS classification highlights 3 conditions like migraine-triggered  
seizure,hemicraniaepileptica and post ictal headache.  
HEMICRANIA EPILEPTICA: 
Criteria include: 
1)Headache lasts for seconds to minutes, with migraine features fulfilling criteria 
3,4. 
2)Partial seizure 
3)Headache develops simultaneously and to the same side of ictal activity. 
4)Complete resolution of headache after fits. 
Its very difficult to differentiate between the post ictal headache and the migraine 
headache which is associated with nausea,vomiting. 
 
 
 
   
 
Post –ictal headache criteria  for diagnosis: 
1)Tension type of headache or migraine type in migraine patients fulfilling criteria 
3,4. 
2)Partial or generalised seizures 
3)Headache occurring within 3hrs of seizure. 
4)Resolution oh headache within 72hrs of seizure. 
Epilepsy and Migraine are chronic disorders with several episodes of neuronal 
dysfunction
21
.Both will come to baseline in  between.Several triggering factors like 
visual ,menstruation,sleepinadequacy,intercurrent illness  will be shared by both of 
theseconditions.Because of the hyperexcitability of cortical neurons  sodium 
valproate like anticonvulsant drugs are used in the migraine prophylaxsis.In  
idiopathic childhood occipital lobe epilepsy and Rolandic epilepsy, migraine and 
migraine like headache can occur.In most patients with occipital lobe epilepsy, 
family history will be positive.25-40% of them  will have headaches following 
fits.Headache that  occurs  during the onset of seizure can be often misdiagnosed as 
migraine.Rolandic epileptics can develop headache during the seizure evolution 
and many of them develop migraine after seizure. 
 
   
 
Table 3.2. Classification of migraine (data from Headache Classification 
Committee of the International Headache Society 1988)
22 
 
Migraine without aura 
Migraine with aura 
   Migraine with typical aura 
   Migraine with prolonged aura 
   Familial hemiplegic migraine 
   Basilar migraine 
   Migraine aura without headache 
   Migraine with acute-onset aura 
Ophthalmoplegic migraine 
Retinal migraine 
Childhood periodic syndromes that may be precursors to or be associated with 
migraine 
   Benign paroxysmal vertigo of childhood 
   Alternating hemiplegia of childhood 
Complications of migraine 
   Status migrainosus 
   Migrainous infarction 
   
 
Unclassifiable migraine-like disorder 
 
 
Migraine is an extremely common condition. Recent epidemiological studies, 
using the IHS criteria, suggest a prevalence in women, between 15 - 20% and in 
men between 5 - 10% and in some studies even higher in women.  There is a 
strong family history, reported in migraine sufferers, particularly in those suffering 
from migraine with aura. 
PATHOPHYSIOLOGY: 
The traditional view of the pathophysiology of migraine has been that of arterial 
spasm within the internal carotid territory resulting in the aura, followed by 
dilatation in the distribution of the external carotid artery, resulting in the 
headache. The original evidence in support of this, included the observation that 
amyl nitrite could temporarily abolish the visual scotoma
23
 and that cerebral 
infarction or occlusion of retinal arteries could both occur during the aura phase, 
showed that the headache is due to arterial dilatation, mainly of the extracerebral 
arteries of the dura and scalp, and other branches of the external carotid, with the 
clinical concomitants of congestion of the conjunctiva and nasal mucosa in some 
patients and pulsation of the superficial temporal artery on the same side where the 
headache is experienced.  
   
 
The specific therapeutic effect of ergotamine is thus interpreted as being due to the 
constriction of the branches of the external carotid artery. This simple 
interpretation, particularly with respect to vasoconstriction, has been challenged 
following the seminal observations of focal hyperaemia followed by a slow spread 
of reduced blood flow which outlasts the aura. This slow spread of oligemia which 
transcends specific arterial territories has been compared to the spreading 
depression of Leao
23
. 
Neuronal depolarization is followed by suppression of neuronal activity, which 
spreads at a rate of approximately 3–4mm/min, independently of the vascular 
territory. This is similar to the rate of spread of reduced blood flow and the 
calculated rate of spread of neuronal dysfunction in the occipital cortex to account 
for the slow progression of the visual scotomata.  
The opportunistic study of a patient undergoing a positron emission tomography 
study who developed a migraine, has confirmed bilateral hypoperfusion starting in 
the occipital lobes and spreading anteriorly at a constant rate, independent of 
cerebral artery territory. The maximal decreases in flow were in the order of 40 per 
cent.Similar studies with functional magnetic resonance imaging demonstrate 
significant reductions in perfusion during the aura phase.Additional evidence 
relating these changes directly to alterations in neuronal excitability have been 
provided by magnetoencephalography with suppression of neuronal signal during 
   
 
the migraine aura.These imaging studies during migraine headache with aura, 
increasingly support the view that, perfusion changes are secondary to a primary 
neuronal dysfunction
24
. 
A number of biochemical correlates of the migraine attack have been observed.  
Serotonin (5-hydroxytryptamine; 5-HT)
25
 constricts large arteries and dilates 
arterioles and capillaries, and there is a widespread subcortico-cortical projection 
system from the midbrain raphe nucleus which utilizes serotonin as its 
neurotransmitter.  
The urinary excretion of the serotonin metabolite 5-hydroxyindolacetic acid is 
increased in severe attacks, indicatingtherelease of serotonin into the 
circulation.Injection of reserpine, which causes release of serotonin, can also 
precipitate attacks in vulnerable subjects. Platelets release serotonin, and platelet 
aggregation is abnormal in migraineurs. Platelets have also been demonstrated to 
have decreased monoamine oxidase activity. 
These observations of platelet abnormality and the fact ,that they release serotonin 
has given rise to the theory that peripheral platelet function is a principal factor in 
the pathogenesis of migrain.It now seems unlikely that an impairment of peripheral 
function is directly responsible ,although it might reflect a more general 
abnormality of serotonin function. Alternatively, these peripheral events may be 
neurally mediated since trigeminal stimulation leads to platelet aggregation and 
   
 
mast-cell degranulation.Importantly, sumatriptan and other newer drugs of the 
same class are potent 5-HT1 agonists. Recent cloning of the 5-HT receptor 
subtypes has resulted in more precise classification and, specifically, sumatriptan 
and its analogues are 5-HT1B (vascular) and 5-HT1D (presynaptic neuronal) 
agonists. 
There is no generally accepted theory that encompasses all of the observed 
vascular changes and the central and biochemical correlates of 
migraine.Trigeminovascular system(neurogenic inflammation)
26
 and a variety of 
vasoactive peptides, including calcitonin-gene-related peptide, are  involved 
inheadache initiation. The release of peptides and the plasma extravasation can be 
blocked by sumatriptan. 
Stimulation of the superior sagittal sinus or meningeal irritation also causes 
activation of the caudal trigeminal nucleus and its extension into the upper cervical 
cord. This can be demonstrated by c-fos immunocytochemistry which indirectly 
demonstrates cellular activation. Activation can also be blocked by antimigraine 
drugs such as dihydroergotamine.Since the sinus and trigeminal nerve supply are 
stimulated directly, the pharmacological antagonism must be central. Importantly, 
neocortical spreading depression will also provoke c-fosimmunoreactivity within 
the trigeminal nucleus.Recently, a PET study during an acute migraine headache 
attack demonstrated an increase in cerebral blood flow within medial brainstem 
   
 
structures which persisted for a time, after symptom relief withsumatriptan. The 
precise location of the increased blood flow was beyond the resolution of the 
imaging system, but might have related to the locus coeruleus and dorsal raphe 
nuclei . 
No adequate theory ,yet exists to encompass all of these observations and, no 
doubt, many further molecular candidates will be proposed. The discovery of the 
importance of nitric oxide as a transmitter, both centrally and peripherally, has also 
directed attention to a possible role in migraine . 
Finally, important advances can be anticipated, arising from the impact of 
molecular genetics on our understanding of migraine. A major clue has come from 
studies of families with cerebral autosomal dominant arteriopathy with subcortical 
infarcts and leucoencephalopathy (CADASIL)
27
.  
 Following demonstration of linkage to chromosome 19 in CADASIL families, 
similar linkage was observed in patients with familial hemiplegic migraine. The 
gene for CADASIL has recently been cloned, and shown to be the Notch 3 gene ,a 
gene with some functional similarities to the presenilins.The potential relationship 
of mutations in this gene to those families with coincidental migraine is unclear. 
By contrast, the linkage to chromosome 19 in families with hemiplegic migraine
28
 
has been established as being due to mutations in a brain-specific P/Q-type calcium 
channel α1-subunit gene, CACNL1A4.The role of this channel in migraine 
   
 
pathophysiology is not yet clear, but progress can be anticipated from transgenic 
mouse models. 
CLINICAL FEATURES: 
The age of onset is often at, or shortly after, puberty and less frequently in middle 
or later life, although in women onset around the menopause does occur, 
sometimes without the accompanying headache, which can lead to diagnostic 
difficulties. Migraine is less common prior to  puberty, but cyclical vomiting and 
motion  sickness are common in children who subsequently develop migraine. The 
frequency of attacks varies largely. Sometimes  they  occur 2-3 times a week, 
whereas   few  may have only one or two eoisodes in their  lifetime. 1-2 attacks per 
month is a common one. Headache  may be more frequent at the time of 
menstruation and commonly decrease  in frequency at the time of  pregnancy. The 
common pattern  is towards reduction in frequency with age, and sometimes the 
headache completely disappears leaving only an aura . 
It is often said that migraine sufferers have a perfectionist or obsessional character, 
but in a disease that is so common, this is difficult to establish. Certainly migraine 
can occur after a period of excitement or excessive work. Sometimes this is due to 
extra sleep at a time of relaxation, so-called weekend migraine. Minor trauma can 
also precipitate migraine ,such as  bright lights and, in some patients, strong smells, 
like wet paint. Dietary precipitants are often sought, but rarely found. Those 
   
 
thought to be responsible include, dairy products, particularly cheese, chocolate, 
fruit, and most commonly caffeine and alcohol. Missing meals may also precipitate 
an attack. 
Headache is the most characteristic symptom of migraine and the one from which 
it derives its name. It may be the only manifestation, where it is referred to as 
migraine without aura (common migraine); indeed this is probably four times as 
common as migraine with aura (classical migraine). The headache may be 
preceded by premonitory symptoms,the most common of which are lassitude, 
hunger, and slight looseness of the bowels. On occasions the patient may feel 
exceptionally well and energetic before an attack. The onset may occur during the 
day, but can awake the patient in the morning, particularly from a heavy, deep 
sleep.Rarely, the attack may awaken the patient during the night. Typically the 
pain is localized to one side, often in the temple, and starts as a boring pain, which 
then gradually spreads until the whole side of the head is affected. As it increases 
in intensity it tends to acquire a throbbing character, which is intensified by 
stooping and by all forms of exertion. Although usually unilateral, a significant 
number of cases become bilateral and often, late in an attack, the pain moves 
posteriorly to an occipital distribution. The headache builds up to a maximum over 
about 30 min and lasts from hours to 1 or 2 days. It is usually relieved by sleep, 
although patients may be left feeling fatigued and with a mild headache while  
   
 
getting up in the next day. In the majority of cases nausea occurs, but only in about 
50 per cent of the patients, vomiting occurs. There is an occasional diarrhoea. 
Photophobia and phonophobia occur during the attacks and patients usually prefer 
to lie quietly in the dark, in contrast to cluster headache, when the patient will 
move around. 
Vasomotor changes are often conspicuous. The face is often pale and the 
extremities cold, until improvement begins, but congestion of the face, 
conjunctiva, and nasal mucosa may occur, often confined to the side of the 
headaches. There may even be subconjunctival haemorrhage or bruising around the 
eyes. The superficial temporal artery on the affected side is often seen to be 
congested and pulsating vigorously, and some patients can obtain temporary relief 
by pressing over the temporal artery or the carotid, although release of 
compression often results in worsening of the headache after a minute or so. There 
is quite often polyuria following recovery from the attack. 
When the headache is accompanied by an aura (migraine with aura)
29
 the aura  
usually precedes, but may accompany, the headache. The headache is 
indistinguishable from that which occurs with migraine without aura, although it 
may be more commonly unilateral. Patients often have a combination of headache 
attacks, both with and without auras. 
   
 
Visual disturbances are the commonest auras
30
. These are usually homonymous, 
involving the corresponding halves of both visual fields, although patients often 
experience them as being worse in one eye than the other.The visual disturbance is 
commonly characterized by positive phenomena at the outset, with a bright spot 
appearing near the centre, or in the periphery, which gradually expands and  the 
advancing edge exhibiting scintillating figures (teichopsia)
31
 which may be 
coloured and angular. The zigzag patterns are characteristic and referred to as 
fortification spectra. The spreading scintillation, leaves behind it an area of 
blindness, so that when it reaches the periphery or the centre of the half-fields the 
patient is hemianopic, although this is  more  often difficult to demonstrate on 
examination. The progression of the visual disturbance lasts from 15 to 20 minutes 
and the hemianopia then gradually fades away. The whole disturbance lasting 
about half an hour, although objects in the affected fields may appear less bright 
than normal for several hours. The disturbance may have a homonymous 
quadrantic distribution, or much less commonly, all peripheral vision is lost in both 
fields, leaving only a „telescopic‟ field of vision.Exceptionally, the hemianopia is 
bilateral, giving temporary blindness. Patients may also experience macropsia or 
micropsia.Auras of paraesthesiae and numbness occur next in frequency. These 
symptoms occur in a „cortical‟ distribution, involving the periphery of the limbs 
and the circumoral region
32
. The upper limb is more often affected, paraesthesiae , 
   
 
beginning in the fingers and gradually spreading up the limb, taking 5–20 min to 
do so. The proximal part of the arm is often relatively spared. The lips, face, and 
tongue may be subsequently affected on one or both sides, or can be involved 
without the upper limbs. Frequently, patients give a history of only half of the 
tongue being affected. The lower limb is only rarely affected. Paraesthesiae usually 
develop shortly after the onset of the visual disturbances, but may occur without 
the latter as the first symptom, or after the headache has been present for several 
hours. Olfactory and auditory hallucinations have been reported, but are rare. Mild 
weakness of the limb, usually the upper, may develop following the paraesthesiae, 
and in rare instances transient hemiparesis occurs with each attack(Hemiplegic 
migraine)
33
.Aphasia is usually of the expressive type and is accompanied by 
dysgraphia. In right-handed people, it is usually associated with visual disturbance 
in the right hemifield and paraesthesiae in the right hand and face. Patients often 
complain of difficulties with concentration, and may feel disorientated in space and 
time. 
The characteristic feature of migraine attacks is the slow speed of the developing 
neurological disturbance. This has been attributed to spreading cortical depression, 
which travels over the cortex at a rate of about 3 mm/min ,by contrast to the rapid 
neural excitatory spread of focal seizures. Similarly, transient ischemic attacks , 
have a much more rapid progression. The characteristic history is of great 
   
 
importance when one encounters patients who have the migrainous aura without 
headache
34
. Attacks often become less frequent with age, with lessening of the 
headache and vomiting, and patients may ultimately only experience the aura. 
TREATMENT: 
Management principles: 
It is very important to explain the patient that 
1)Since migraine is caused by his genes it could not be cured but can be controlled. 
2) Drugs and lifestyle changes will influence headache severity. 
3) Migraine will not cause death but can cause serious morbidity. 
4)Migraine management needs patient co-operation. 
NONDRUG THERAPY; 
Regular diet,healthy lifestyle ,relaxation therapy and avoiding precipitating factors 
like coffee and chocolates, alcohol intake and avoidance of stressful life can alter 
the prognosis of migraine. Extensive changes in diet are usually unrewarding. 
Concomitant drugs should be reviewed, such as vasodilator drugs and the oral 
contraceptive pills. 
 
 
   
 
PREVENTIVE MANAGEMENT: 
The basis for preventive strategy  is a combination of acute attack frequency and 
also the attacktractability.Severeheadches and headache lasted for more than 15 
days per month for more than 3months require additional prophylaxis
40
.Several 
drugs starting from beta blockers,tricyclics,Calcium channel antagonists,and 
anticonvulsants like sodium valproate are available to treat migraine 
recurrence.Minimum of 6 months, the prophylaxis drugs have to be continued for 
full clinical benefit.Always start in low dose then gradually titrate according to the 
response.Neuromodulation therapy in the form of occipital nerve stimulation is a 
promising one which modified the thalamic pain integration. This is an interesting 
and developing one. 
Drug treatment can be divided into two categories, namely treatment of the attack 
and prophylaxis
34
. Many attacks can be controlled by aspirin, paracetamol, or other 
simple analgesics, in combination with an antiemetic drugs such as domperidone. 
The key is to take the drug early in the treatment. Narcotic analgesics should be 
avoided. The mainstay of symptomatic treatment has, in the past, been ergotamine 
or dihydroergotamine. This still has a role, although one has to be aware of the 
dangers of exceeding a weekly dose of 2–4 mg, the problems of frequent, even 
small doses, and the fact that ergotamine in itself can cause headache in overdose. 
Recently, the introduction of the 5-HT1B/1D agonist, sumatriptan, and similar drugs 
   
 
such as naratriptan, rizatriptan, and zolmitriptan, are rapidly becoming first-line 
treatment for the acute attack.Sumatriptan is effective in migraine with or without 
aura, both as an oral and a subcutaneous preparation.Subcutaneous administration 
of 6 mg of sumatriptanimprovesnearly 90 per cent of migraine attacks .The 
headache, in responders, settles in 30 min or so, and only a few patients require 
further doses. 
 Migraine attacks in relation to the menstrual cycle can be treated prophylactically 
on a more circumscribed basis. Aspirin, twice daily, may be effective ,but the three 
mainline drugs are the 5-HT antagonist pizotifen, the β-adrenoreceptor antagonist 
propanolol, and sodium valproate. These all have a  similar efficacy. However, 
each has side-effects, and propanolol is contraindicated in patients with asthma, 
and sodium valproate should be used with caution in women of childbearing age 
who may become pregnant. 
Methysergide is highly effective, but in view of the side-effect of retroperitoneal 
fibrosis, is only reserved for treatment-resistant cases. Some patients, particularly 
those with more frequent attacks,will respond well to tricyclic antidepressants, 
often in low dosage, such as amitriptyline10-25 mg/day.Patients with status 
migrainosus are best admitted to hospital for fluid replacement, correction of 
electrolyte imbalance, and management of the nausea and vomiting. Some patients 
may benefit from treatment with steroids. 
   
 
MIGRAINE VARIANTS: 
1.OPHTHALMOPLEGIC MIGRAINE: 
This term has been applied to recurrent attacks of headache, usually orbital or 
retro-orbital, associated with paralysis of one or more oculomotor nerves. 
Although transient diplopia may occur with migraine, the isolated oculomotor 
palsies of ophthalmoplegic migraine can rarely persist for days or weeks after the 
attack, and sometimes become permanent .The third nerve is most commonly 
involved, but rarely the fourth, and the first division of the fifth may be affected. 
The diagnosis should be accepted with care when used to account for ocular palsies 
lasting more than an hour or two, as many such cases hitherto described may have 
had intracranial aneurysms. However, in a review of the ophthalmological 
complications of migraine, theophthalmoplegia, either isolated or recurrent, 
occurring in migrainous attacks, often remained unexplained despite full 
investigation. 
Ophthalmoplegic migraine appears to be extremely rare.  Many structural lesions 
can give rise to a similar feature, and in particular, Tolosa–Hunt syndrome, which 
is responsive to steroids, can mimic ophthalmoplegicmigraine.The diagnosis 
should not be accepted without scrupulous investigation and neuroimaging. 
 
 
   
 
2.HEMIPLEGIC MIGRAINE: 
Transient hemiparesis can occur with migraine headache. Hemiplegic migraine can 
be sporadic or familial. The EEG during the attacks may show slow waves over the 
hemisphere contralateral to the hemiplegia, but neuroimaging is usually norma 
.Respiratory arrest during  an attack, may lead to death.Occasionally a mild CSF 
pleocytosisoccurs.In sporadic hemiplegic migraine, the weakness can affect 
alternate sides. In the familial form, it is usually on the same side. A mutation in a 
brain-specific calcium channel α1-subunit gene has been linked to familial 
hemiplegic migraine . 
3.BASILAR MIGRAINE: 
In 1961, Bickerstaff described attacks of migraine, starting most commonly during 
adolescence, in which the symptoms of the aura suggested,ischaemia in the 
distribution of the posterior circulation .The attacks commonly begin with classical 
visual disturbances of migraine which are usually bilateral, followed by 
paraesthesiae of the lips, hands, and feet. Dysarthria and diplopia in association 
with severe occipital headache may then follow. Impairment of consciousness with 
stupor has been attributed to involvement of the brainstem reticular formation . 
 
 
 
   
 
4.RETINAL MIGRAINE: 
Unilateral photopsia, monocular altitudinal defects, and transient monocular 
blindness indicate involvement of the retinal circulation and, when occurring in 
isolation with migraine headache, suggest a diagnosis of retinal migraine. 
Thrombosis of the central retinal artery and of single branches may occur and 
recurrent attack of retinal ischaemia may lead to bilateral optic atrophy due to 
ischaemic papillopathy.Some patients with retinal migraine have  aortic valve 
abnormalities on echocardiography. 
5.LOWER HALF MIGRAINE: 
Some patients experience episodic pain which is predominantly in the nose, ear, 
and neck, referred to as lower-half headache or facial migraine. Recurrent attacks 
of cervical pain with tenderness over the carotid (carotidynia) may occur in 
association with migrainous headaches, and in such cases the symptoms usually 
respond to antimigrainepreparations . 
COMPLICATIONS OF MIGRAINE: 
Rarely  patients can have  very frequent attacks of headache, and finally  the 
migraine, with a  persistent aura, may last  many days with little to no relief (status 
migrainosus).Most commonly dehydration and fatigue are the contributing 
factors.Sometimes, a persistent  hemiparesis can occur in hemiplegic 
migraine.Likewise , a hemianopia may persist  & sometimes   associated with 
   
 
prolonged positive visual phenomena. In these situations  CT evidence of 
ischaemic infarction  may be  seen.Some patients with the antiphospholipid 
antibody syndrome ,develop increasing attacks of migraine and are at risk of 
migraine-associated cerebral infarction. The presence of antiphospholipid 
antibodies is an independent risk factor for cerebral infarction and such patients 
with a combination of migraine and antibodies should be anticoagulated. It is often 
assumed that in patients with a permanent visual field defect, hemiparesis, aphasia, 
or ophthalmoplegia, an intracranial vascular anomaly (e.g. aneurysm or angioma) 
will be present, but a review of cases of „complicated migraine‟ showed that 
investigations designed to demonstrate such lesions are usually negative .An 
association between the migraine and seizure  has been found in some clinical  
studies and occasionally a seizure event  can occur at the height of a severe  
migraine attack. 
CLUSTER HEADACHE: 
MIGRAINOUS NEURALGIA: 
The term cluster headache was introduced by Kunklereferring to the characteristic 
pattern of attacks occurring in clusters. This has superseded the earlier term of 
„periodic migrainous neuralgia‟ applied by Harris.Syndromes referred to by earlier 
neurologists as ciliary neuralgia, vidian neuralgia, and sphenopalatine neuralgia are 
   
 
almost certainly the same condition ,the terminology reflecting various theories of 
pathogenesis in vogue at the time. 
The headache is highly distinctive and involves chiefly the eye and frontal region 
on one side and is characterized by its periodicity. Attacks may occur once or 
several times in 24 hours and last from 10 minutes to, rarely, several hours. The 
pain is intense, even leading to attempted suicide; it is continuous and of „boring‟ 
or „burning‟ character. Typically the attacks may awaken the patient from sleep in 
the early morning, coincident with the first REM (rapid eye movement) state. 
During the attack, the patient paces up and down, in contrast to the behaviour in 
migraine attacks. 
 An attack tends to last for several weeks, after which the patient is free from 
symptoms for months or even 1–2 years before the headache recurs. Lacrimation 
and nasal congestion on the affected side, occur during the attack. Some patients 
have a sense of facial and palatal swelling ipsilaterally, which can occasionally be 
observed.There are no abnormal physical signs, although a Horner's syndrome, 
either transient or permanent, sometimes develops on the affected side and has 
been attributed to damage to the sympathetic fibres in the wall of the carotid artery. 
 Cluster headache is most common in males and usually begins in the third or 
fourth decade.It is far less common than migraine. In headache clinics, the ratio of 
migraine to cluster headache patients has been reported to be as high as 10 : 
   
 
50.However, patients with cluster headache are far more likely to be referred to a 
specialist clinic and this overestimates the prevalence. Population-based studies in 
the USA suggest a prevalence for men of 0.4 per cent and for women of 0.08 per 
cent . Overall prevalence is unlikely to be more than 0.1 per cent. The fact that it 
can be precipitated by vasodilator drugs such as nitroglycerine and histamine or by 
alcohol, and that acute attacks are relieved by oxygen, has suggested that 
vasodilation might be involved. However, this is difficult to demonstrate.  
The autonomic features are due to parasympatheticactivation.During an attack, an 
increase in neuropeptides, namely calcitonin gene related peptide (CGRP) and 
vasoactive intestinal polypeptide (VIP), the latter a marker for parasympathetic 
activity, have been found in ipsilateral jugular blood. 
In view of the clustering, prophylactic  therapy is  the mainstay of treatment for 
those with very regular attacks. Education and explanation is important, including 
the avoidance of triggering factors, such as alcohol, during a cluster. Altitude may 
also precipitate attacks. Verapamil (80 mg four times a day) is an effective 
prophylactic, followed by lithium with appropriate monitoring of levels. 
Combination with a late-night ergotamine preparation, either orally or as a 
suppository, may help those patients whose attacks are typically triggered during 
early sleep.Prednisolone (40 mg daily in a reducing  dose over 3 weeks) can be 
   
 
valuable but should only be given in a short course.Other drugs that may have 
benefit include propranolol, methysergide, and pizotifen
36
. 
For acute attacks, ergotamine preparations are efficacious, and subcutaneous 
sumatriptan (6 mg) is effective in the majority of patients ,Oxygen inhalation in 
effective but the equipment can be cumbersome
37
.The typical history provides the 
diagnosis and extensive investigation is not required. The non-specialist may 
misinterpret the history as being trigeminal neuralgia, and in some instances, an 
overlap syndrome can occur, the so-called „cluster–tick syndrome‟, often related to 
vascular compression .Glaucoma should rarely cause confusion but is an important 
diagnosis, not to miss. Occasionally, cluster headache can be symptomatic of 
lesions in the cavernous sinus, and atypical histories or those occurring for the first 
time in the young or old should prompt investigation. 
In some patients, the periodicity does not occur.The Headache Classification 
Committee criteria for chronic cluster headache is that, the attacks of pain occur 
for more than a year on a daily basis without a remission lasting longer than 2 
weeks. This chronic cluster headache may develop de novo or follows, episodic 
cluster headache with increasing periods of attack and reducing remission time. 
Patients with chronic cluster headache often require lithium. 
 
 
   
 
 PAROXYSMAL HEMICRANIA: 
Paroxysmal hemicrania shares, with cluster headache the unilateral severe ocular 
or periorbital and frontal pain , with associated autonomic disturbances of 
lacrimation, rhinorrhoea, and conjunctival injection. The attacks are very frequent, 
ranging from 2 to as many as 40 times a day, and tend to be shorter than those of 
cluster headache, ranging from a couple of minutes to half an hour .The key feature 
of chronic paroxysmal hemicrania is the response to indometacin in a dose of 150 
mg a day or less. This is an absolute criterion for the diagnosis. 
More recently, episodic paroxysmal hemicrania has been described with a 
periodicity similar to that of cluster headache, but otherwise the same features as 
chronic paroxysmal hemicrania. Hemicrania continua can also be episodic or 
chronic and is characterized by a constant hemicranial headache with exacerbations 
that can be associated with ipsilateral autonomic features. The sine qua non of the 
diagnosis of the hemicranias is the absolute responsiveness to indomethacin. 
Short-lasting, unilateral neuralgiform headache attacks with conjunctival injection 
and tearing (SUNCT) syndrome is characterized by very brief attacks of unilateral 
headache with autonomic phenomena
38
. The attacks  last only  from 30 seconds to 
2 minutes and may occur many times in an hour. These paroxysmal headaches are 
all very rare. 
   
 
There are several causes for secondary headache .Ophthalmological,dental and 
Otological problems can produce headache.Several intra and extracranial lesions 
and systemic problems were also included as the cause for headache. 
ALTERATIONS OF NEURONAL EXCITABILITY IN EPILEPSY: 
A number of factors can control neuronal excitability.These include voltage-gated 
ionchannels, neurotransmitter ligand activated ion channels,neuromodulators and 
second messenger systems
15
.Ligand gated ion channels are responsible for 
communication between the cells while voltage gated channels determine, how 
inhibitory and excitatory influences are integrated in a way that determines the 
propagation of impulses to other neurons
37
. 
VOLTAGE GATED CHANNELS: 
Voltage gated ion channels are membrane-spanning proteins composed of different 
subunits that when open permit the passage of ions.Most channels will open on 
depolarization of the membrane but some open when the membrane is 
hyperpolarized.Voltage gated sodium channels are intimately involved in the 
propagation of action potentials,the rapid upstroke being due to an opening of fast 
transient channels at about -60Mv.The importance of voltage gated sodium 
channels in human epilepsy is further emphasised by the finding of molecular 
   
 
abnormalities in families with generalised epilepsy and febrile seizures and in 
patients with severe myoclonic epilepsy of infancy. 
Voltage dependent calcium channels contribute to dendritic spikes,slow somatic 
depolarizations and associated burst discharges and by doing so trigger 
neurotransmitter release.Six subclasses of calcium channels are known to 
exist.L,N,T,P,Q and R,T channels have a low threshold of activation at around -
70mV.They inactivate relatively rapidly.These channels are found, in high 
concentrations in thalamic neurons and play an important role in generation of 
generalised spike wave discharges. A mutation of CACNA1A has been found in a 
patient with absence epilepsy
34
. 
Voltage gated potassium channels are very diverse in their nature.They appear to 
play an important role in the regulation of repetitive firing by prolonging the after-
spike hyperpolarization and slowing down the firing rate.Mutations of KCNQ2 and 
KCNQ3 encoding K+ channels subunits can lead to benign neonatal 
convulsions.The potentiation of voltage dependent potassium currents being 
explored as a potential target for new antiepileptic drugs. 
INHIBITORY NEUROTRANSMISSION:  
GABA is the major inhibitory neurotransmitter in the forebrain,being present at 
approximately 30% of all synapses in the central nervous system.Binding of 
   
 
GABA leads to an opening of the chloride and potassium ion channels and 
resultant hyperpolarization.
16
The activity of benzodiazepines and barbiturates at 
GABAa receptor appears to be responsible for their antiepileptic activity.Mutations 
of GABRG2 gene encoding for GABAa subunits have been found in generalised 
epilepsy and febrile seizures
34
. 
EXCITATORY NEUROTRANSMISSION: 
The major excitatory neurotransmitters are the amino acids L-glutamate and L-
aspartate.They exert their synaptic influences by interacting with a number of 
different types of receptors.AMPA
33
 receptor is probably responsible for the 
majority of the rapid excitatory neurotransmission.Thekainate receptor is also 
coupled to a channel permeable to sodium and potassium.Opening of channel 
allows the entry of both sodium and calcium.This acts as an amplification 
mechanism that leads to prolonged activation of already excited neurons and 
associated burst firing. 
Calcium entry may also ultimately result in excitotoxicity and cell 
death.Excitatoryaminoacidsare also able to interact with metabotropic receptors 
that activate second messenger systems to influence  biochemical pathways and ion 
channels.These receptors are found both presynaptically and 
postsynaptically.Activation usually results in presynaptic inhibition and 
   
 
postsynaptic excitation.These receptors may have an important role in supporting 
epileptic activity. 
ACETYLCHOLINE RECEPTORS
33
: 
They serve as ligand gated sodium channels.Mutation of a gene,CHRNA4,which 
encodes for the beta2 sub unit of the receptor has been associated with autosomal 
dominant frontal lobe epilepsy. 
EPILEPTIC ACTIVITY IN NEURONAL SYSTEMS: 
While molecular changes may predispose to burst firing of 
neurons,synchronization of such activity,necessary for seizures also require the 
involvement of neuronal circuits. 
FOCAL EPILEPTOGENESIS: 
The most studied and clinically relevant model of focal seizures and 
epileptogenesis is the hippocampus and hippocampal sclerosis, is the most 
common form of focal epilepsy in man.Mesial temporal structures are 
interconnected by a reverberating loop involving entorhinalcortex,dentate 
gyrus,CA3,CA1pyramidal neurons.Normal spontaneous activity of CA3pyramidal 
neurons consists of paroxysmal depolarization shifts and associated burst firing of 
the cell body and apicaldendrites.In normal brain, bursting activity in CA3 neurons 
   
 
will  evoke, bursts in connected neurons(30%)
34
.This probably increases when the 
pyramidal cell is excited by many inputs simultaneously.Three phenomena 
implicated.Cellloss,Mossy fibre sprouting and Neurogenesis may all enhance the 
potential for seizure generation while resulting in pathological change that can lead 
to hippocampal sclerosis.In the kindling model of epilepsy, repeated sub-
convulsive electrical stimulation,usually to the amygdale leads to increasing after 
discharge and ultimately to behavioural seizures. 
It appears that limbic structures are particularly sensitive to the development of 
kindling when compared to neocortex, a situation that is reflected in man,where the 
temporal lobe is by far the most common site of seizure onset.In the pilocarpine 
model of chronic epilepsy, seizures can induce neurogenesis,neurons being 
abnormally integrated into existing circuits.These changes  therefore provide a 
potential basis for the clinical predisposition of the mesial temporal structure to 
produce seizures and a plausible mechanism for some of the progressive changes 
that may be seen as part of drug-resistant epilepsies. 
GENERALISED EPILEPSIES: 
In generalised epilepsies, there will be a very generalised disturbance of neuronal 
activity in both hemispheres.2 schools of thought exist.One study specifies that , it 
is  primarily a cortical process. In an another study, there is an unspecified 
   
 
centrencephalic system in which structures of the upper brainstem and thalamus 
are responsible for generating the spike wave discharge and driving a cortical 
synchrony
34
exists. 
The cellular substrate for these phenomena is now well understood.It is dependent 
on a thalamocortical circuit  that includes the nucleus reticularisthalami.The 
circuits involve excitatory glutaminergic synapses and inhibitory 
gabanergicsynapses.The behaviour of thalamic neurons and the circuit is largely 
determined by the presence of a high density of calcium channels,which results in 
Ca2/k dependent burstfiring.Theseinturn can give rise to strong inhibitory 
postsynaptic potentials mediated by GABAb receptors in thalamo cortical relay 
neurons
34
. 
This circuitry is important in activating cortical neurons during sleep-waking 
cycles.Tonic activity in the relay neuron occurs during wakefulness and during  
rapid eye movement sleep,but they fire in the burst mode during NREM 
sleep
39
.During drowsiness and sleep, thalamic neurons hyperpolarize and begin to 
exhibit typical repetitive burst firing that contributes to sleep spindles in the 
EEG.The classic anti-absence drug ethosuximide acts by causing a voltage 
dependent blockade of T-type calcium currents, a property shared by 
valproate.Hyperpolarization and burst firing is greatly facilitated by GABAnergic 
activity via GABAbmechanisms. 
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METHODS AND MATERIALS 
The present study had been conducted at Government RajajiHospital,Madurai 
Medical College,Madurai during the period between March 2012 and 
February2013.I have obtained written consent from the patient, after explaining 
about the study in detail. I got the ethical committee clearance, for this study from 
Madurai Medical College,Madurai. The outpatients registered at the Epilepsy 
clinic, Government Rajaji Hospital, Madurai Medical college during a one year 
period between  March2012 and February2013 were taken up for the study. The 
clinical details were obtained from the epilepsy clinicoutpatient register/case sheets 
and patient interviews with the help of the priorly prepared proforma.I have taken 
details on demographic profile,seizure history and treatment  history by 
interviewing the patient and from the case history with the help of standard 
questionnaire. I have asked the patients, torecord the seizure and headache 
occurrencedetails in a diary. Associated symptoms, as well asprecipitating factors 
for the headache will be noted by them.The diary will be scrutinizedmonthlyduring 
the period of the survey. Headache Impact Test (HIT-6) would be done to assess 
the headache impact in patient‟s daily life. 
 
 
   
 
Study Design: 
Prospective cross sectional observation study. 
Period of study: 
March 2012 to February 2013. 
Study population:  
300 epileptic patients who attended the  Epilepsy Outpatient Clinic, 
GovernmentRajaji Hospital, Madurai Medical College between March2012 an 
February 2013. 
Inclusion criteria: 
1.Patients registered at the Epilepsy outpatient clinic, 
GovernmentRajajiHospital,Madurai. 
2. Known Patients with Primary Generalised Epilepsy. 
3. Agreed to participate in the study. 
4.More than 12 years of age. 
Exclusion criteria: 
1.Patient‟s refusal to participate in the study. 
   
 
2.Patients having nonepilepticattacks, symptomatic  fits like metabolic 
causes,toxins induced and meningoencephalitis. 
3.Patients with neurodevelopmental disorders. 
4.Mentally challenged persons,patients on antipsychotics. 
5.Pregnancy and  CNS malignancy. 
6.Focal seizures. 
7.Patients already on  prophylactic drugs for headache. 
8.Epileptic patients on tablet sodium valproate. 
Definitions: 
 Seizure and the epileptic syndromes were classified according to the guidelines of  
ILAE. 
Preictal headache: 
It  is defined as the headache which occurs ≥30 mts prior to  the seizure 
andcontinuedtill the seizure onset. 
 
 
   
 
Ictal Headache: 
It occurs simultaneously with the seizure onset  and postictal headache occurs 
immediately after the stoppage of seizure event. 
Periictal headache: 
Periictal headache is the combination of headache which occurs during preictal, 
ictal and in the immediate postictal state. 
Interictalheadache: 
Those headaches which occur during theInterictal period and the headache will not 
be related directly to the seizure. The   Headache was classified based on the 
patient‟s statement. 
CALCULATION OFSAMPLE SIZEAND ANALYSIS OF STATISTICS: 
Around 300 patients with known primary generalised epilepsy were followed up 
over a one year period between March2012 and February2013, who attended the 
epilepsy outpatient clinic.P-value of<0.05 was consideredsignificant statistical 
value to correct for the multiple comparisons. SPSS13.0 is used for statistical 
analysis. 
   
 
 
   
 
 
 
 
 
RESULTS AND ANALYSIS 
 
 
 
 
   
 
RESULTS AND ANALYSIS 
 
In the present study which was conducted  over  1year observation  period, totally 
248 patients(out of 300 recruited)  completed the study and they were  analysed . 
Their  mean age was 36.30years  and 123(49.60%) of them were female, and 125 
were male (50.40%)(Table 1). Average duration of seizure disorder was 
6.52yrs.The total number of patients developed headache was 72(29%) and 
without headache was 176(70.97%)(Table2).Of the 72 patients developed 
headache, 27 were male and 45 were female patients.(Table3) 
Among the 72(29%) patients with headache,54(21.7%) patients developed  
headache in the interictal period and 10(4.03%) in the periictal period and 
8(3.22%) patients developed headache both in the periictal as well as in the 
interictal period(Table4). 27(10.9%) Patients had developed migraine type of 
headache and 20(8.06%)patients had tension type headache and 25(10.08%) 
patients developed nonspecific headache. In the present study, this reveals that 
migraine is the most common type of headache in patients suffering from 
epilepsy,.In the interictal period,21 patients developed tension type  of headache 
and 17 had developed migraine headache & 16 patients developed tension type of 
headache .This showed that patients with nonspecific headache predominates in the 
interictal period.(Table5) 
   
 
Among the 10 patients developed headache in the interictal period 5 had migraine 
without aura and 2 developed tension type  headache & 3patients presented with  
nonspecific  headache.8 patients developed headache bothin the interictal and 
periictalperiod.Of them,4 had migraine with aura and 1 developed migraine 
without aura & 2patients developed tension type headache ,1patient had 
nonspecific headache.This also showed, that patients with migraine headache 
predominated the periictal period as well as  the periictal+interictal period, in the 
present study. 
TOTAL HEADACHE EPISODES IN THE STUDY PERIOD: 
 72 patients developed 223 headache episodes during the study period. Among the 
223 headache  episodes ,the migraine  with aura was 52, migraine without aura was 
39 and tension type of  headaches were 63 and  nonspecific  headache episodes 
were 69(p-value 0.117).In the present study, the migraine type of headache  
occurred  in large number  followed  by tension  type headache  and nonspecific 
headache. In the periictal period, the total number of headache episodes, the 
patients developed was 52. Among the 52 headaches, the migraine headache 
episodes were 31, tension type of  headache was 11 and 10 nonspecific headache 
episodes.p-value for this is 0.004 which is statistically significant value. This 
reveals  that migraine is the most frequent type of headache in the periictal 
period.(Table8)   
   
 
HEADACHE OCCURRENCE IN RELATION TO SEIZURE FREQUENCY: 
(Table9) 
Among the 158 patients, with seizure frequency of >3per month, 60(37.97%) 
patients developed headache. Total number of patients with seizure frequency of 1-
3 per month is 60. Among the 60 patients, 10(16.66%) patients developed 
headache. Among the 30 patients with seizure frequency of 0-1 per month, 2 
(6.66%) patients  developed headache. The present study showed  that, the 
incidence of headache increases whenever the seizure frequency also increases, 
from 6.66%(0-1seizure/month)and 16.66%(1-3seizure/month) to 
37.97%(>3seizure/month) and clearly reveals the relation between the headache 
occurrence with the number of seizure episodes. The p-value for this, is 0.005 
which is statistically significant. 
HIT Score :( Table10) 
In the present study,72 patients developed various headaches .Among the 72 
patients  with  headache, 36(50%) patients  showed very severe impact in HIT 
score and 16 (22.22%) patients  developed, little or no impact in their life, due to 
headache.The p-value for this is 0.026 which is statistically significant.HIT score 
reveals that  the headache influenced  most of the patient‟s daily life  negatively. 
 
   
 
Seizure frequency per month: 
•Total no of patients→ 248 
•No of patients with >3 episode/ month→158 
• 1-3 episode/month→60 
•0-1 episode /month→30 
The average seizure frequency was 9.09 during the study period. 
No of patients developed headache during the study: 
Total no of patients with headache→72 (29%) 
•Male→27 (10.88%) 
•Female→45 (18.14%) 
No of patients with headache, in relation to seizure event: 
•Total no of patients with headache→  72(29%) 
•No ofpatients with Interictal headache→54 (21.7%) 
•No of patients with periictal headache→10 (4.03%) 
•No of patients with both interictalplusperiictal headache→8 (3.22%)  
   
 
The average headache episode per person was 3.09 duringthe study period. 
Total no of patients with headache 72 :(Table 3) 
Types: 
1.Migraine headache→ 27(10.88%) 
•Migraine with aura→14 (5.64%) 
•Migraine without aura→13 (5.24%) 
2. Tension headache→20 (8.06%) 
3. Non specific headache→25 (10.08%) 
TOTAL NUMBER OF HEADACHE EPISODES→223 (Table 6) 
•Interictal headache→171 
•Periictal headache→52 
 Total no of headache episode : 223(Table7) 
•Migraine with aura→52 
•Migraine without aura→39 
•Tension type headache→63 
   
 
•Nonspecific headache→69 
Total no of Interictal headache:  171 
•Migraine with aura →38 
•Migraine without aura→22 
•Tension type headache→52 
•Nonspecific headache→59 
Total no of Periictal headache episode:  52 
•Migraine with aura→14 
•Migraine without aura→17 
•Tension type headache →11 
•Nonspecific headache→10 
   
 
SEX DISTRIBUTION [TABLE 1] 
 
total male 125 50.40% 
total female 123 49.60% 
  248   
 
 
 
   
 
 
NUMBER OF PERSONS WITH HEADACHE [TABLE 2] 
 
 
 
 
 
 
 
headache 72 29% 
no headache 176 70.97% 
  248   
   
 
 
NUMBER OF PERSONS WITH HEADACHE IN RELATION WITH SEX 
[TABLE 3] 
 
 
 
 
 
 
 
headache male 27  
headache female 45  
  72 29.00% 
   
 
 
NUMBER OF PATIENTS WITH HEADACHEIN  RELATION  TO 
SEIZURE  PERIOD [TABLE 4] 
 
 
 
 
 
 
 
 
 
 
 
 
 Seizure period 
 Number 
of 
persons 
with 
headache 
among 
total 
inter ictal 54 21.7% 
periictal 10 4.03% 
inter +periictal 8 3.22% 
   
 
NUMBER OF PATIENTS WITH HEADACHE IN RELATION TO 
SEIZURE [TABLE 5] 
 
type of headache 
inter 
ictal 
only 
periictal 
only 
inter 
ictal 
+perictal total 
among 
total pts 
migraine with aura 10 0 4 14 5.64% 
migraine without aura 7 5 1 13 5.24% 
tension headache 16 2 2 20 8.06% 
non specific headache 21 3 1 25 10.08% 
total 54 10 8 72  
 
 
 
 
 
   
 
 
TOTAL NUMBER OF HEADACHE EPISODES [TABLE 6] 
 
interictal 171 
periictal 52 
 
 
 
 
   
 
 
NUMBER OF HEADACHE  EPISODE  IN RELATION TO SEIZURE 
PERIOD [TABLE 7] 
 
 
 
 
 
 
 
 
 
 
type of 
headache inter ictal periictal 
migraine 
with aura 38 14 
migraine 
without 
aura 22 17 
tension 
headache 52 11 
non 
specific 
headache 59 10 
total 171 52 
   
 
 
TOTAL NUMBER OF HEADACHE IN PERIICTAL PERIOD [TABLE 8] 
 
migraine 31 
tension 11 
non specific 10 
total 52 
 
p value = 0.004 
 
 
 
 
 
 
 
 
   
 
 
NUMBER OF PERSONS WITH HEADACHE IN RELATION TO SEIZURE 
FREQUENCY [TABLE 9] 
 
 
Seizure frequency/month headache no headache total 
>3 60 98 158 
1-3 10 50 60 
0-1 2 28 30 
total 72 176 248 
  
p value= 0.005 
 
 
 
   
 
 
HIT  (HEADACHE  IMPACT TEST)  SCORE [TABLE 10] 
category total male female 
little/no impact 16 5 11 
some impact 12 7 5 
substantial impact 8 5 3 
very severe 36 10 26 
total 72 27 45 
P value=0.026 
 
 
 
 
   
 
 
 
 
 
 
DISCUSSION 
 
 
 
 
   
 
DISCUSSION 
Epilepsy and Migraine are the chronic disorders with recurrent neurological 
dysfunction associated with headache and autonomic, abdominal and psychotic 
features. In some patients it may be difficult to differentiate between migraine and 
the seizure episodes. Both are having comorbid symptoms and occurrence. The 
present study had been conducted at Government Rajaji Hospital, Madurai Medical 
College, Madurai during the period between March 2012 and February 2013.  
In the present study  which  was  conducted  over  1year  observation  period, 
totally 248 patients(out of 300 recruited)  completed  the study  and  they were  
analysed . Their mean age was 36.30years and 123(49.60%) of them were female, 
and 125 were male (50.40%). Average duration of seizure disorder was 6.52yrs .In 
the previous study by P.Kwan et al
2
, totally around 306 patients with epilepsy were 
recruited and 227 of them completed the study. The mean age was 36 years and 
98(43.2%) of them were female and 129(56.8%) were male patients. The mean 
duration of epilepsy in the study group was 16years. 
In the Multicenter study from HELP (Headache in Epileptic Patients)
3
 group study, 
597 patients with epilepsy were recruited. The mean age was 34.9years and 
348(58.3%) of them were female and 249(41.7%) were male patients. The mean 
   
 
duration of epilepsy in the study group was 8years.The data of the present study 
were closer with P.Kwan et al study and Multicenter study from HELP group. 
In the current study,the total number of patients developed headache was 72(29%) 
and without headache was 176(70.97%).Of the 72 patients developed headache, 27 
were male and 45 were female patients. InP.Kwan et al study, the total no of 
patients with headache was 50(22%) and without headache was 77(78%) and in 
HELP group study the total no of patients with headache was 169(28.3%) and 
without headache was 428(71.69%). 
In the present study,54 (21.7%) patients developed Interictal headache and 
10(4.03%) patients developed periictal headache and 8(3.22%) patients developed, 
headache in both periictal and in the interictalperiod.This data was consistent with 
the study from P.Kwan and Multicenter  study group.InP.Kwan study, 45(19.8%) 
patients developed headache in interictal period and 11(4.8%) patients developed 
periictal headache &5(2.2%) patients developed headache both in interictal as well 
as in the periictal period. 
In the Multicenter study group,146(24.4%) patients developed headache in 
interictal period and 35(5.9%) patients developed periictal headache. 
 
 
   
 
INCIDENCE OF MIGRAINE IN SEVERAL STUDY GROUPS: 
1. In the present study→10.9% 
2. InMulticenter study group→12.4% 
3. InP.Kwan et al study group→7.92% 
4. In Korean study group
5→6.5% 
Our study results were consistent with other studies.Migraine prevalence in most 
of the studies was 8-20%. 
NO OF PATIENTS WITH MIGRAINE IN PERIICTAL PERIOD: 
In the Present study→50% 
In Multicenter study group→46.2% 
In Yankovsky et al study
12→36% 
In Leniger et al study
8→56% 
The percentage of migraine patients intheperiictal period was similar to other 
studies.33% of patients with Interictal headache, had developed migraine type of 
headache which is closer to P.Kwan study, where 23% of patients in the Interictal 
period, developed migraine typeof headache. 
   
 
In the present study 27(10.9%) patients developed migraine headache and in 
Multicenter study group, 74(12.4%) developed migraine and in the P.Kwanstudy 
18(7.9%) had migraine attacks. 
HEADACHE OCCURRENCE WITHTHE SEIZURE FREQUENCY: Among the 
158 patients, with seizure frequency of >3per month, 60(37.97%) patients 
developed headache. Total number of patients with seizure frequency of 1-3 per 
month is 60. Among the 60 patients, 10(16.66%) patients developed headache. 
Among the 30 patients with seizure frequency of 0-1 per month, 2 (6.66%) patients  
developed headache. The present study showed  that, the incidence of headache 
increases whenever the seizure frequency also increases, from 6.66%(0-
1seizure/month)and 16.66%(1-3seizure/month) to 37.97%(>3seizure/month) and 
clearly reveals the relation between the headache occurrence with the number of 
seizure episodes. The p-value for this, is 0.005 which is statistically significant. 
  
But in most of the other studies (Leniger et al
8
, Forderreuther et al
7 
Karaali-Savrun 
et al
9
) there was no specific association of headache and seizure frequency was 
noted. In the present study, 29% of patients with primary generalised epilepsy 
haddeveloped migraine headache but in Multicenter study
3
 there wasno such 
   
 
correlation, but 30-50% of the patients with occipital lobe epilepsy developed 
migraine with aura as a predominant seizure related headache. 
 Cortical spreading depression considered to be the mechanism of migraine aura, 
and characterised by transient increases in the metabolic and electrical activity & 
cerebral blood flow, followed by sustained decreases, spreading from the posterior 
to anterior cerebral area. Therefore the occipital lobe could be the brain structure 
most responsible for the development of migraine. Migraine, seizure related 
headache might be more likely to occur in association with occipital lobe epilepsy. 
HIT SCORE AND ITS IMPACT ON PATIENT‟S DAILY LIFE: 
 In the present study,72 patients developed various headaches .Among the 72 
patients  with  headache, 36(50%) patients  showed very severe impact in HIT 
score and 16 (22.22%) patients  developed, little or no impact in their life, due to 
headache.The p-value for this is 0.026 which is statistically significant.HIT score 
reveals that  the headache influenced  most of the patient‟s daily life  negatively.In 
P.Kwan et al
2
 study,34% of the patients with headache developed very severe 
impact in their life. 
The current study measured the incidence of headache, in epileptic patients 
prospectively. In this study nonepileptic patients, as control have not included for 
direct comparison of incidenceof headache between the patients and the common 
   
 
population. In a prior, communitybased retrospective survey, patients recalled their 
headacheforaprolongedperiodand 37.2% of them developedheadache. Control 
group might be added in future studies. This study showed the incidence of 
headache in relation to the seizure frequency. This might help the statistical 
capacity to analyze other things whichmay be associated with headache, like 
epilepsy syndrome, typeof seizure& antiepileptic drug details. 
This study suggests that Migraine is a frequent comorbid disorder  in patients  with  
epilepsy  and an important   factor which  affects  the occurrence and type  of 
seizure related headache. 
This study also demonstrates that seizure related headache is a common 
accompanying symptom of seizure, causes major impairment in daily life. The 
links between the epilepsy, seizure related headache and migraine are an important 
subject for future investigation. 
Headache is under diagnosed mostly,inspiteof the lower incidence in this study. 
The headache interferes the patient‟s lifestyle and influenced his life negatively. So 
we have to give more importance, in the diagnosis of headache even with patients 
having low frequency of seizure episode. Large studies with more number of 
patients, control group are required for the risk factor identification and to evaluate 
the treatment strategies to reduce its impact. 
   
 
 
 
 
 
 
SUMMARY 
 
 
 
 
   
 
SUMMARY 
•Total duration of observational study period →1year 
•Total no of patients studied→248 
•Total no of patients with headache→   72 (29%) 
•Total no of patients with Interictal headache→54 (21.7%) 
•Total no of patients with periictal headache→10 (4.03%) 
•Total no of patients with both interictalplusperiictal headache→8 (3.22%)  
The average headache episode per person was 3.09 duringthe study period.  
Total no of patients with headache 72: 
Patients with Headache: 
1. Migraine headache→ 27(10.88%) 
•Migraine with aura→14 (5.64%) 
•Migraine without aura→13 (5.24%) 
2. Tension headache→20 (8.06%) 
3. Non specific headache→25 (10.08%) 
   
 
In the present study,patientswith migraine headache predominated theother type of 
headache like, tension type headache and other nonspecific headache. The 
frequency of migraine is more in the periictal period than in the Interictal period. 
HEADACHE INCIDENCE VERSUS SEIZURE FREQUENCY: 
The present study showed that incidence of headache increases, whenever the 
seizure frequency also increases, from 6.66%(0-1seizure/month) and 16.66%(1-
3seizure/month) to 37.97%(> 3seizure/month)  and clearly reveals the relationship 
between the headache occurrence with the number of seizure episodes per month. 
The p-value for the current study is 0.005 which is statistically significant. 
HIT SCORE AND ITS IMPACT ON PATIENT‟S LIFE: 
 In the present study,72 patients developed various headaches .Among the 72 
patients  with  headache, 36(50%) patients  showed very severe impact in HIT 
score and 16 (22.22%) patients  developed, little or no impact in their life, due to 
headache.The p-value for this is 0.026 which is statistically significant.HIT score 
reveals that  the headache influenced  most of the patient‟s daily life  negatively. 
   
 
 
 
 
 
 
CONCLUSION 
   
 
CONCLUSION 
1.The present study showed  the incidence of headache among the epileptic 
patients and its impact on their daily life. 
2.In the present study, the headache incidence increases with the seizure 
frequency,whichreiterates thefactthat,adequate seizure control is essential to reduce 
the incidenceof headache inpatients with epilepsy. 
3.Headache incidence in epileptic patients can be considerably ameliorated by 
choosing appropriate drug that will be useful for both seizure and headache. 
4. This study  demonstrates  (HIT score) that  seizure related headache is a 
common accompanying  symptom of  seizure,  causes  major impairment in daily 
life. Hence, by reducing the incidence of headache, we can improve the quality of 
life in patients with epilepsy.   
5.This study also suggests that migraine is a frequent comorbid disorder  in 
patients  with  epilepsy  and an important   factor which  affects  the occurrence 
and type  of seizure related headache. 
6 The links between the epilepsy, seizure related headache and migraine are an 
important subject for future investigation. 
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STUDY PROFORMA 
Name      : 
Age/sex     : 
OP No     : 
Chief complaint    : 
Duration of Epilepsy   : 
Seizure occurrence   : 
Type of Headache    : 
Duration of Headache   : 
RelationshipofHeadachewith Epilepsy:  
Treatment details    : 
Type of Headache    : 
Female patients-pregnant(yes/no) : 
Associated fever and Headache with seizures-To rule out CNS infection: 
Previous H/O intracranial space occupying lesion: 
Previous H/O psychiatric illness or antipsychotic intake: 
  
 
   
 
 HEADACHE IMPACT TEST  QUESTIONNAIRE 
Name:_____________________________ Date:____________ 
Please circle the response that best describes how you feel  and calculate the totals below. 
 
1. When you have headaches, how often is the pain severe? 
A) Never B) Rarely C) Sometimes D) Very Often E) Always 
2. How often do headaches limit your ability to do usual daily activities including 
household work, work, school, or social activities? 
A) Never B) Rarely C) Sometimes D) Very Often E) Always 
3. When your have a headache, how often do you wish you could lie down? 
A) Never B) Rarely C) Sometimes D) Very Often E) Always 
4. In the past 4 weeks, how often have you felt too tired to do work or daily activities 
because of your headaches? 
A) Never B) Rarely C) Sometimes D) Very Often E) Always 
5. In the past 4 weeks, how often have you felt fed up or irritated because of your 
headaches? 
A) Never B) Rarely C) Sometimes D) Very Often E) Always 
6. In the past 4 weeks, how often did headaches limit your ability to concentrate on 
work or daily activities? 
A) Never B) Rarely C) Sometimes D) Very Often E) Always 
 
 
# of A’s  
Multiply by 6 points each 
 
# of B’s 
Multiply by 8 points each 
   
 
# of C’s 
Multiply by 10 points each 
 
 
# of D’s 
Multiply by 11 points each 
 
# of E’s 
Multiply by 13 points each 
 
Note: # = Number 
 
HIT-6 score : 
 
Bonus Questions 
On a scale of 0-10, with “10” being the worst discomfort imaginable above the shoulders, and a “0” is 
no 
pain at all (you feel fabulous), how many mornings per week do you wake with a “0”, that is, you feel 
fabulous?_______ 
On those mornings that you wake “with a number”, what‟s the average number that you have? 
_________ 
 
Your headaches are having a very severe impact on your life. You may be experiencing disabling pain 
and other symptoms that 
are more severe than those of other headache sufferers. Don‟t let your headaches stop you from 
enjoying the important things in 
your life, like family, work, school or social activities. 
Make an appointment today to discuss your HIT-6 results and your headaches with your doctor. 
 
 
If You Scored 56 – 59 
Your headaches are having a substantial impact on your life. As a result you may be experiencing 
severe pain and other 
 
symptoms, causing you to miss some time from family, work, school, or social activities. 
Make an appointment today to discuss your HIT-6 results and your headaches with your doctor. 
 
 
If You Scored 50 – 55 
Your headaches seem to be having some impact on your life. Your headaches should not make you 
miss time from family, 
work, school, or social activities. 
Make sure you discuss your HIT-6 results and your headaches at your next appointment with your 
doctor. 
   
 
 
 
If You Scored 49 or Less 
Your headaches seem to be having little to no impact on your life at this time. We encourage you to 
take HIT-6 monthly to 
continue to track how your headaches affect your life. 
 
 
If Your Score on HIT-6 is 50 or Higher 
You should share the results with your doctor. Headaches that are disrupting your life could be 
migraine. 
 
 
   
 
MASTER CHART 
 
 
s.no age sex 
seizure 
duration headache 
no of 
headache 
seizure episodes per 
month seizure associated headache types of headache 
HIT >3 1 to3 0 to 1 
inter 
only 
peri 
only inter+peri m + a m - a ten ns 
                                  
1 45 f 3 0 - 
 
1 1 
       
- 
2 23 m 7 0 - 
  
1 
       
- 
3 43 m 2 0 - 
  
1 
       
- 
4 32 f 8 1 3 1 
  
1 
    
1 
 
63 
5 45 f 3 0 - 
 
1 1 
       
- 
6 23 m 8 1 1 1 
   
1 
  
1 
  
62 
7 21 f 2 0 - 
  
1 
       
- 
8 43 m 6 0 - 
 
1 1 
       
- 
9 56 f 1 1 4 1 
  
1 
  
1 
   
57 
10 34 f 8 0 - 
  
1 
       
- 
11 21 m 3 0 - 
 
1 1 
       
- 
12 35 f 8 0 - 
  
1 
       
- 
13 67 m 1 0 - 
 
1 
        
- 
14 53 f 7 0 - 
 
1 1 
       
- 
15 63 m 1 1 3 1 
  
1 
    
1 
 
46 
16 56 f 7 1 4 1 
  
1 
     
1 53 
17 43 f 1 0 - 
 
1 1 
       
- 
18 46 f 4 0 - 
 
1 
        
- 
19 37 m 8 0 - 
 
1 1 
       
- 
20 35 f 1 0 - 
 
1 
        
- 
   
 
21 27 m 2 1 3 1 
  
1 
  
1 
   
48 
22 26 m 7 0 - 
 
1 
        
- 
23 35 f 1 0 - 
 
1 1 
       
- 
24 37 m 5 0 - 
 
1 1 
       
- 
25 36 f 2 1 3 1 
   
1 
  
1 
  
64 
26 36 f 1 1 2 1 
  
1 
    
1 
 
62 
27 27 f 8 0 - 
 
1 
        
- 
28 27 m 6 0 - 
 
1 
        
- 
29 24 f 4 0 - 
 
1 
        
- 
30 35 m 2 1 4 1 
  
1 
  
1 
   
47 
31 17 f 1 1 3 1 
   
1 
    
1 43 
32 32 m 8 0 - 
 
1 
        
- 
33 53 m 7 0 - 
 
1 
        
- 
34 46 m 3 1 3 1 
  
1 
    
1 
 
48 
35 35 m 7 0 - 
 
1 
        
- 
36 23 f 4 1 3 1 
  
1 
     
1 41 
37 43 m 8 0 - 
 
1 
        
- 
38 57 f 5 0 - 
 
1 1 
       
- 
39 45 m 8 0 - 
 
1 
        
- 
40 43 f 7 0 - 
 
1 1 
       
- 
41 36 m 3 0 - 
 
1 
        
- 
42 25 f 5 0 - 
 
1 1 
       
- 
43 43 m 6 1 6 
  
1 1 
   
1 
  
52 
44 35 m 4 0 - 
 
1 
        
- 
45 25 m 7 0 - 
          
- 
46 43 f 9 1 5 
 
1 
 
1 
    
1 
 
64 
47 44 f 6 0 - 
          
- 
   
 
48 45 f 8 1 4 1 
   
1 
    
1 44 
49 36 m 5 0 - 
 
1 
        
- 
50 42 m 7 0 - 
          
- 
51 36 m 4 1 2 1 
  
1 
    
1 
 
60 
52 43 m 7 0 - 
          
- 
53 36 f 8 0 - 
 
1 
        
- 
54 17 m 4 0 - 
  
1 
       
- 
55 32 f 5 1 2 1 
  
1 
     
1 63 
56 54 f 6 0 - 
          
- 
57 26 f 8 1 3 1 
    
1 1 
   
57 
58 43 m 4 0 - 
          
- 
59 35 f 9 1 2 1 
  
1 
    
1 
 
41 
60 25 f 6 0 - 
          
- 
61 43 m 8 0 - 
 
1 
        
- 
62 27 m 5 1 3 1 
   
1 
    
1 46 
63 26 m 7 0 - 
          
- 
64 24 f 4 0 - 
 
1 
        
- 
65 23 m 8 0 - 
          
- 
66 34 f 7 1 2 1 
  
1 
     
1 53 
67 42 m 6 0 - 
 
1 
        
- 
68 36 m 9 1 4 1 
  
1 
    
1 
 
59 
69 32 f 4 0 - 
          
- 
70 45 m 7 0 - 
          
- 
71 23 m 5 0 - 
          
- 
72 34 f 8 0 - 
          
- 
73 45 f 2 1 3 1 
  
1 
   
1 
  
63 
74 54 m 7 0 - 1 
         
- 
   
 
75 43 f 3 1 3 1 
  
1 
    
1 
 
41 
76 32 f 9 0 - 
  
1 
       
- 
77 26 f 6 1 5 
 
1 
 
1 
     
1 42 
78 45 m 7 0 - 
  
1 
       
- 
79 43 f 5 1 3 1 
  
1 
    
1 
 
65 
80 32 f 3 0 - 
  
1 
       
- 
81 26 m 6 0 - 
 
1 
        
- 
82 43 m 8 1 4 1 
  
1 
    
1 
 
54 
83 35 f 5 0 - 
 
1 
        
- 
84 25 m 7 0 - 
 
1 1 
       
- 
85 45 m 3 0 - 
 
1 
        
- 
86 36 f 8 0 - 
 
1 
        
- 
87 33 m 6 1 2 1 
  
1 
  
1 
   
61 
88 24 f 4 0 - 
 
1 
        
- 
89 44 m 7 0 - 
 
1 
        
- 
90 26 f 9 1 2 1 
  
1 
   
1 
  
42 
91 21 f 6 0 - 
 
1 
        
- 
92 36 m 7 0 - 
 
1 
        
- 
93 45 m 5 1 3 1 
  
1 
     
1 48 
94 26 f 9 0 - 
 
1 
        
- 
95 36 m 6 0 - 
  
1 
       
- 
96 42 m 5 1 4 1 
   
1 
  
1 
  
46 
97 26 f 7 0 - 
  
1 
       
- 
98 26 f 8 1 1 1 
  
1 
     
1 58 
99 43 m 6 0 - 
  
1 
       
- 
100 36 f 9 0 - 
  
1 
       
- 
101 42 f 5 1 2 1 
  
1 
     
1 53 
   
 
102 36 f 4 0 - 
  
1 
       
- 
103 15 m 8 0 - 
  
1 
       
- 
104 36 f 8 1 5 
 
1 
 
1 
     
1 59 
105 42 f 6 0 - 
 
1 
        
- 
106 36 m 9 0 - 
 
1 
        
- 
107 25 m 7 1 4 1 
  
1 
     
1 58 
108 41 f 4 0 - 
 
1 
        
- 
109 37 m 7 0 - 
 
1 
        
- 
110 52 m 8 0 - 
 
1 
        
- 
111 43 f 6 0 - 
 
1 
        
- 
112 42 m 8 0 - 1 
         
- 
113 27 m 5 0 - 
 
1 
        
- 
114 41 f 4 0 - 
 
1 
        
- 
115 37 f 9 1 3 1 
  
1 
    
1 
 
63 
116 26 f 5 0 - 
 
1 
        
- 
117 31 m 9 0 - 1 
         
- 
118 37 f 7 0 - 1 
         
- 
119 26 m 8 0 - 1 
         
- 
120 24 m 9 0 - 1 
         
- 
121 41 m 7 1 4 1 
  
1 
   
1 
  
63 
122 35 f 4 0 - 1 
         
- 
123 72 m 6 0 - 1 
         
- 
124 63 f 7 0 - 1 
         
- 
125 68 f 9 1 4 1 
   
1 
   
1 
 
54 
126 46 f 6 0 - 1 
         
- 
127 36 m 2 0 - 1 
         
- 
128 24 f 10 0 - 1 
         
- 
   
 
129 23 m 9 1 1 1 
  
1 
  
1 
   
47 
130 34 f 7 0 - 1 
         
- 
131 52 m 8 0 - 1 
         
- 
132 36 m 5 0 - 1 
         
- 
133 42 m 14 1 3 1 
  
1 
     
1 48 
134 43 f 9 0 - 1 
         
- 
135 47 m 8 0 - 1 
         
- 
136 27 m 5 0 - 1 
         
- 
137 43 f 7 1 4 1 
  
1 
    
1 
 
57 
138 37 f 4 0 - 1 
         
- 
139 32 m 6 0 - 1 
         
- 
140 36 f 3 0 - 1 
         
- 
141 37 m 7 1 2 1 
  
1 
    
1 
 
57 
142 25 f 5 0 - 1 
         
- 
143 43 m 9 0 - 1 
         
- 
144 35 f 4 1 3 1 
  
1 
     
1 64 
145 42 f 1 0 - 1 
         
- 
146 36 m 5 0 - 1 
         
- 
147 36 m 6 1 2 1 
  
1 
     
1 47 
148 26 f 4 0 - 1 
         
- 
149 44 m 77 0 - 1 
         
- 
150 35 m 8 0 - 1 
         
- 
151 25 f 5 1 3 1 
    
1 1 
   
54 
152 37 f 3 0 - 1 
         
- 
153 34 m 6 0 - 1 
         
- 
154 35 m 4 1 2 1 
  
1 
     
1 54 
155 36 f 8 0 - 1 
         
- 
   
 
156 32 m 9 0 - 1 
         
- 
157 34 f 7 1 3 1 
   
1 
  
1 
  
62 
158 26 f 8 0 - 1 
         
- 
159 25 f 5 1 4 
 
1 
 
1 
   
1 
  
43 
160 28 m 7 0 - 1 
         
- 
161 27 f 7 1 5 
 
1 
 
1 
    
1 
 
42 
162 32 f 8 0 - 1 
         
- 
163 34 m 5 0 - 1 
         
- 
164 42 f 7 1 1 1 
    
1 
  
1 
 
43 
165 26 f 6 0 - 1 
         
- 
166 37 m 4 0 - 1 
         
- 
167 27 f 2 1 4 
 
1 
 
1 
     
1 53 
168 24 f 8 0 - 1 
         
- 
169 26 m 6 0 - 1 
         
- 
170 27 f 9 1 7 
 
1 
   
1 1 
   
57 
171 23 f 6 0 - 1 
         
- 
172 34 m 4 0 - 1 
         
- 
173 45 m 8 0 - 1 
         
- 
174 47 f 4 1 2 1 
  
1 
  
1 
   
41 
175 45 f 6 0 - 1 
         
- 
176 38 m 2 0 - 1 
         
- 
177 36 f 5 1 2 1 
    
1 
   
1 63 
178 33 m 7 0 - 1 
         
- 
179 46 m 4 0 - 1 
         
- 
180 26 f 8 0 - 1 
         
- 
181 44 f 6 1 3 1 
  
1 
   
1 
  
42 
182 36 m 2 0 - 1 
         
- 
   
 
183 36 m 1 0 - 1 
         
- 
184 42 m 12 0 - 1 
         
- 
185 24 m 8 1 1 1 
  
1 
     
1 61 
186 38 f 5 0 - 1 
         
- 
187 29 m 9 0 - 1 
         
- 
188 31 f 6 1 3 1 
  
1 
  
1 
   
43 
189 49 f 8 0 - 1 
         
- 
190 43 m 7 0 - 1 
         
- 
191 37 m 9 1 2 1 
  
1 
     
1 57 
192 42 f 8 0 - 1 
         
- 
193 37 m 9 0 - 1 
         
- 
194 56 m 5 0 - 1 
         
- 
195 46 f 7 1 3 1 
    
1 
  
1 
 
44 
196 43 f 5 0 - 1 
         
- 
197 26 m 3 0 - 1 
         
- 
198 33 f 6 0 - 1 
         
- 
199 35 f 9 1 2 1 
  
1 
     
1 41 
200 47 m 7 0 - 1 
         
- 
201 39 f 5 0 - 1 
         
- 
202 25 m 9 0 - 1 
         
- 
203 48 m 7 1 6 
 
1 
 
1 
  
1 
   
59 
204 36 f 4 0 - 1 
         
- 
205 38 m 9 0 - 1 
         
- 
206 42 m 7 0 - 1 
         
- 
207 56 f 6 1 2 1 
  
1 
     
1 43 
208 43 f 13 0 - 1 
         
- 
209 37 m 9 0 - 1 
         
- 
   
 
210 25 f 7 0 - 1 
         
- 
211 18 f 8 1 3 1 
  
1 
     
1 42 
212 35 m 9 0 - 1 
         
- 
213 27 f 8 0 - 1 
         
- 
214 42 m 4 1 5 
 
1 
   
1 
 
1 
  
45 
215 34 f 7 0 - 1 
         
- 
216 27 m 6 0 - 1 
         
- 
217 26 m 3 0 - 1 
         
- 
218 26 f 14 1 2 1 
  
1 
     
1 53 
219 15 f 11 0 - 1 
         
- 
220 35 m 10 0 - 1 
         
- 
221 52 f 8 1 3 1 
  
1 
  
1 
   
59 
222 45 f 7 0 - 1 
         
- 
223 33 m 6 0 - 1 
         
- 
224 27 f 7 1 5 
 
1 
  
1 
   
1 
 
52 
225 18 f 6 0 - 1 
         
- 
226 29 m 5 0 - 1 
         
- 
227 26 m 7 0 - 1 
         
- 
228 48 m 9 1 5 
  
1 
  
1 1 
   
48 
229 58 f 8 0 - 1 
         
- 
230 57 m 6 0 - 1 
         
- 
231 47 f 4 1 2 1 
  
1 
   
1 
  
58 
232 38 f 9 0 - 1 
         
- 
233 25 m 8 0 - 1 
         
- 
234 19 m 7 1 2 1 
   
1 
  
1 
  
53 
235 32 f 8 0 - 1 
         
- 
236 36 m 7 0 - 1 
         
- 
   
 
237 26 m 3 0 - 1 
         
- 
238 45 f 6 1 3 1 
  
1 
  
1 
   
54 
239 26 f 9 0 - 1 
         
- 
240 56 m 7 0 - 1 
         
- 
241 47 m 9 1 2 1 
  
1 
    
1 
 
52 
242 36 f 5 0 - 1 
         
- 
243 46 m 3 0 - 1 
         
- 
244 38 m 8 0 - 1 
         
- 
245 36 f 9 0 - 1 
         
- 
246 24 m 4 0 - 1 
         
- 
247 43 m 10 0 - 1 
         
- 
248 35 m 12 0 - 1 
         
- 
                                  
    
1=presence 
 
1 = presence 
  
 
   
 
   
 
   
 
 
 
 
  
   
 
 
